Dalfampridine ER (Generic for Ampyra)

Introducing Dalfampridine ER prepared to the Ampyra standard—a potassium channel blocker designed to improve walking speed and mobility in multiple sclerosis patients. By enhancing nerve conduction and motor function while reducing fatigue, this formulation delivers improved gait performance and an enhanced quality of life with advanced, targeted therapy.